Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04746677 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
A NA study of Abdominal Aortic Aneurysm and Aortic Dissection, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT04746677: Recruiting NA study of Abdominal Aortic Aneurysm and Aortic Dissection, sponsored by Beth Israel Deaconess Medical Center.
NCT04746677 is a NA study of Abdominal Aortic Aneurysm and Aortic Dissection that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 180 participants, below the 443-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04746677, a NA study of Abdominal Aortic Aneurysm and Aortic Dissection, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to examine the safety and effectiveness of physician-modified endovascular grafts (PMEGs) for endovascular repair of complex aortic pathology in high-risk patients. The study is divided into three study arms based on the subject's aortic pathology: (1) Complex abdominal aortic aneurysm (AAA); (2) Thoracoabdominal aortic aneurysm; and (3) Aortic dissection.
Primary Outcome
Rate of death
Conditions Studied
Interventions
- DEVICE Endovascular aortic repair with a physician-modified endovascular graft (PMEG)
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT04746677 shows while recruiting
NCT04746677 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 443-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (59% lower).
The record links to 3 conditions, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Endovascular aortic repair with a physician-modified endovascular graft (PMEG) is the first listed.
NCT04746677 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04746677 about?
NCT04746677 is a clinical study titled "Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)". The primary objective of this study is to examine the safety and effectiveness of physician-modified endovascular grafts (PMEGs) for endovascular repair of complex aortic pathology in high-risk patients. The study is divided into three study arms based on the subject's aortic pathology: (1) Complex ...
What is the current status of trial NCT04746677?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2021-03-15. Estimated completion is 2030-12-31.
What conditions does trial NCT04746677 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm, Aortic Dissection, Thoracoabdominal Aortic Aneurysm.
What interventions are being tested in trial NCT04746677?
The interventions under investigation include: Endovascular aortic repair with a physician-modified endovascular graft (PMEG) (DEVICE).
Who is sponsoring clinical trial NCT04746677?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04746677 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04746677's enrollment target sits among peer trials
180 9th of 16 higher than 8 of 16 other Abdominal Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques
RECRUITING · NA
-
3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair
ACTIVE NOT RECRUITING · NA
-
Post-Approval Study of the TREO Abdominal Stent-Graft System
ACTIVE NOT RECRUITING · NA
-
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
COMPLETED · NA
-
Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI